載入...
Chemoresistance and targeted therapies in ovarian and endometrial cancers
Gynecological cancers are known for being very aggressive at their advanced stages. Indeed, the survival rate of both ovarian and endometrial cancers is very low when diagnosed lately and the success rate of current chemotherapy regimens is not very efficient. One of the main reasons for this low su...
Na minha lista:
| 發表在: | Oncotarget |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Impact Journals LLC
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5354810/ https://ncbi.nlm.nih.gov/pubmed/28008141 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.14021 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|